A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition
Autori
Maggiori informazioni sul libro
The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.
Acquisto del libro
A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition, Roland T. Skeel
- Lingua
- Pubblicato
- 2007
- Rilegatura
- (In brossura),
- Condizioni del libro
- In buone condizioni
- Prezzo
- 9,99 €
Metodi di pagamento
Ancora nessuna valutazione.
- Titolo
- A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition
- Lingua
- Inglese
- Autori
- Roland T. Skeel
- Pubblicato
- 2007
- Formato
- In brossura
- Pagine
- 817
- ISBN10
- 0781765315
- ISBN13
- 9780781765312
- Serie
- Descrizione
- The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.